Methotrexate for Immune Related Arthritis or Arthralgias (IMPACT 2.1)

Clinical trial NCT06001125 · TERMINATED

Trial details

NCT number: NCT06001125
Sponsor: AHS Cancer Control Alberta
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Arthritis Arthralgia

Start date: 2024-08-12
Primary completion: 2025-06-17
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.